Loading organizations...
§ Private Profile · Mountain View, CA, USA
Medical technology company developing non-invasive focused ultrasound for brain disease treatment, opening the blood-brain barrier.
Based in Mountain View, California, Cordance Medical develops non-invasive medical technologies that utilize focused ultrasound to temporarily open the blood-brain barrier for the treatment of central nervous system diseases. The company's flagship pre-clinical NeuroAccess platform is specifically designed to facilitate targeted therapeutic delivery for oncology and neurodegenerative conditions, maintaining a primary focus on glioblastoma and other severe brain cancers. Operating as a venture-backed medical device enterprise, the firm has successfully secured more than $8 million in an oversubscribed seed financing round to advance its ongoing clinical development efforts. To support its complex research and clinical strategy, the organization maintains an expert advisory team featuring prominent faculty members from Stanford University, Duke University, and the Barrow Neurologic Institute. Cordance Medical was originally founded by ultrasound pioneer Bhaskar Ramamurthy alongside medical co-founders Eric Leuthardt and Hong Chen.
Cordance Medical has raised $8.0M across 1 funding round.
Cordance Medical has raised $8.0M in total across 1 funding round.
Cordance Medical has raised $8.0M in total across 1 funding round.
Cordance Medical's investors include Deborah Kilpatrick, Angel Physicians Fund, National Brain Tumor Society, R42 Group, Shanda Group, SmartGate, Sontag Foundation.
Cordance Medical has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Seed in November 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 24, 2025 | $8M Seed | Deborah Kilpatrick | Angel Physicians Fund, National Brain Tumor Society, R42 Group, Shanda Group, SmartGate, Sontag Foundation | Announced |